Sophia Davidson
…team she identified new pathways of inflammatory signalling triggered by genetic mutations which disrupt cell homeostasis, such as the loss of function mutations in proteasome subunits or COP-I complex components….… Read more
…team she identified new pathways of inflammatory signalling triggered by genetic mutations which disrupt cell homeostasis, such as the loss of function mutations in proteasome subunits or COP-I complex components….… Read more
…Communications 2023). A/Prof Gantier’s focus is twofold Understanding how innate immune sensors misfire, with the goal of preventing autoimmunity. Developing a new class of anti-inflammatory molecules, known as RNA therapeutics,…… Read more
Dr Catherine Carmichael is a molecular cancer biologist whose research is focused on identifying the key mechanisms driving Acute Myeloid Leukaemia (AML) progression and developing novel therapeutic approaches to treat…… Read more
A/Prof Yang is an endocrine hypertension researcher and clinician who has demonstrated the high prevalence of Primary Aldosteronism (PA) in the community and is now leading research to enable early…… Read more
A specialist in the fields of tumour immunology and mass spectrometry techniques, Dr Pouya Faridi’s goal is to discover innovative targets that can drive the development of cutting-edge precision immunotherapies…… Read more
Associate Professor Tate is an international leader in the fields of viral pathogenesis and immunotherapies. She has made significant contributions to understanding the process by which viral infections cause disease…… Read more
Dr Renata Libianto is a research fellow in the Endocrine Hypertension Research Group and a clinical endocrinologist. Since graduating with a MBBS from the University of Melbourne in 2012, she…… Read more
Hamid Bidkhori is a cell and molecular biologist with a medical training background. He has three years of experience as a postdoctoral researcher in immunology and also served as an…… Read more
…underpinning the transition at birth in preterm and compromised newborns, can targeted, personalised treatments be developed to reduce global morbidity and mortality”. + Read more Diseases we research Birth asphyxia…… Read more
Professor Claudia Nold is a world-renowned inflammation and cytokine biology expert. Her research interest is on inflammation and anti-inflammatory treatments, with a focus in newborn. She has established a translational…… Read more